Article and Video CATEGORIES

Cancer Journey

Search By

Dr. Gupta is currently an Oncology Fellow at Johns Hopkins Sidney Kimmel Comprehensive Cancer Center

For information on Dr. Gupta see the following links - 

Hopkins Medicine Kimmel Cancer Center

ASCO

Supportive Care Video Series: Malignant Ascites or Fluid in the Belly
dbrock
Author
Arjun Gupta, MD, Advisory Board Member, GRACE Faculty
Image
GRACE is very happy to bring to you more videos from our program, Supportive Care in Cancer Treatment.

In this video our host, Dr. Arjun Gupta speaks with Shaalan Beg, MD, with UT Southwestern Medical Center in Dallas, TX . Dr. Beg and Dr. Gupta discuss Malignant Ascites, or fluid in the belly, in patients with cancer.  
Ascites is the fluid that can accumulate within the peritoneal cavity.  Cancers of the colon/rectum, ovary, breast, lung, pancreas, liver and lymphoma are generally the most common cancers that may develop ascites.    

 

For further information, Drs. Gupta and Beg have recently also published a patient page in JAMA Oncology - you can view the patient page here: 

https://jamanetwork.com/journals/jamaoncology/fullarticle/2757397  or view the document below.

  


 

A huge thankyou to our sponsors who have made this series possible! 


To join the conversation, visit https://cancergrace.org/forum.

To find additional CancerGRACE resources, visit https://cancergrace.org.

To donate to CancerGRACE, visit https://cancergrace.org/donate.

 

 

Video Language

Next Previous link

Previous PostNext Post

Related Content

Online Community

An antibody–drug conjugate (ADC) works a bit like a Trojan horse. It has three main components:

  1. The antibody, which serves as the “horse,” specifically targets a protein found on cancer...

Bispecifics, or bispecific antibodies, are advanced immunotherapy drugs engineered to have two binding sites, allowing them to latch onto two different targets simultaneously, like a cancer cell and a T-cell, effectively...

The prefix “oligo–” means few. Oligometastatic (at diagnosis) Oligoprogression (during treatment)

There will be a discussion, “Studies in Oligometastatic NSCLC: Current Data and Definitions,” which will focus on what we...

Radiation therapy is primarily a localized treatment, meaning it precisely targets a specific tumor or area of the body, unlike systemic treatments (like chemotherapy) that affect the whole body.

The...

Biomarkers are genetic mutations (like EGFR, ALK, KRAS, BRAF) or protein levels (like PD-L1) in tumor cells that help guide personalized treatment, especially NSCLC, directing patients to targeted therapies or immunotherapies...

Hi Stan!  So good to hear from you.  I'm sorry for the late response.  I too have been out of town with family and missed your post, probably because I was...

It is so good to hear from you!  And I am so happy to hear that your holidays have been good and that you are doing well.  It sounds like your...

Recent Comments

JOIN THE CONVERSATION
Biomarkers
By JanineT GRACE … on
Radiation Therapy
By JanineT GRACE … on
Oligometastatic vs Oligoprogression
By JanineT GRACE … on
Hi Stan!! and happiest of holidays!
By dbrock on